[Response to aflibercept in patients with fibrovascular pigment epithelial detachment refractory to ranibizumab in exudative age-related macular degeneration]
- PMID: 28336285
- DOI: 10.1016/j.jfo.2016.11.007
[Response to aflibercept in patients with fibrovascular pigment epithelial detachment refractory to ranibizumab in exudative age-related macular degeneration]
Comment on
-
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.N Engl J Med. 2011 May 19;364(20):1897-908. doi: 10.1056/NEJMoa1102673. Epub 2011 Apr 28. N Engl J Med. 2011. PMID: 21526923 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical